Bill Gates made donations to MIT through Jeffrey Epstein (both Jews) here are all of the tech mogul's connections to the financier.
“Now, an additional connection was reported by The New Yorker, which obtained emails from MIT Media Lab directors that say the convicted sex offender "directed" Gates to donate $2 million to the research lab in October 2014.“
https://www.google.com/amp/s/www.businessinsider.com/bill-gates-connections-jeffrey-epstein-mit-donations-ronan-farrow-2019-9%3famp
MIT Technology Review
What are the best coronavirus treatments?
“Here’s a list of promising drugs being tried on people infected with the virus. by Antonio Regalado February 25, 2020”
https://www.technologyreview.com/s/615284/what-are-the-best-coronavirus-treatments/
“Minimize the attack surface: 2019-nCoV jumped from an animal, most probably a bat, to humans. China has now banned the wildlife trade in response to the epidemic. Keeping it banned would be prudent, but won’t be possible in all nations. Still, there are other methods of protection. Influenza viruses commonly jump from birds to pigs to humans; the new coronavirus may have similarly passed through a livestock animal. Thanks to CRISPR, we can now edit the genomes of most livestock. If we made them immune to known viruses, and introduced those engineered traits to domesticated animals everywhere, we would create a firewall in those intermediate hosts. We might even consider heritably immunizing the wild organisms most likely to serve as reservoirs of disease.
“None of these defenses will be cheap, but they’ll be worth every penny.”
Rapid diagnostics: We need a reliable method of detection costing just pennies to be available worldwide inside of a week of discovering a new virus. This may eventually be possible thanks to a technology called SHERLOCK, which is based on a CRISPR system more commonly used for precision genome editing. Instead of using CRISPR to find and edit a particular genome sequence in a cell, SHERLOCK programs it to search for a desired target and initiate an easily detected chain reaction upon discovery. The technology is capable of fantastic sensitivity: with an attomolar (10-18) detection limit, it senses single molecules of a unique DNA or RNA fingerprint, and the components can be freeze-dried onto paper strips.”
https://leapsmag.com/how-emerging-technologies-can-help-us-fight-the-new-coronavirus/
Crossing the Species Barrier — One Small Step to Man, One Giant Leap to Mankind.
https://www.nejm.org/doi/full/10.1056/NEJMp048039
Huagui Chen- cofounder The Wuhan Institute of Virology was the Plant General Manager Guangzhou at Plastic Omnium- in Wuhan China
https://www.apollo.io/people/Huagui/Chen/54ebae847468694311621c0d
Shi Zhengli is a Chinese virologist and writer. She is a researcher at the Wuhan Institute of Virology, which is part of the Chinese Academy of Sciences. Shi and her colleague Cui Jie found that the SARS virus originated in bats. Shi is a member of the Virology Committee of the Chinese Society for Microbiology.
https://en.m.wikipedia.org/wiki/Shi_Zhengli
lab in Australia announced on 28 January that it had obtained virus samples from an infected person who had returned from China. The team was preparing to share the samples with other scientists. Labs in France, Germany and Hong Kong are also isolating and preparing to share virus samples they obtained from local patients, says Bart Haagmans, a virologist at Erasmus Medical Center in Rotterdam, the Netherlands. “Probably next week we will get isolates from one of the different labs,” he says.
https://www.nature.com/articles/d41586-020-00262-7
“Israel got a jump on the coronavirus crisis because researchers had already created a vaccine against avian coronavirus Infectious Bronchitis Virus (IBV), which affects poultry, according to the Jewish Press. The IBV vaccine has already passed clinical trials at Israel's Veterinary Institute.
By "pure luck," the MIGAL team selected a poultry coronavirus to test their new vaccine technology, which doesn't target any specific virus, according to Dr. Chen Katz, biotechnology group leader at MIGAL. Katz told the Press and Post that after the current COVID-19 virus broke out in China, the researchers studied the new virus and realized it was genetically similar to IBV and that the infection mechanism was the same. They now are confident they can adjust the system to combat COVID-19.
The new vaccine, which would be orally administered, faces pre-clinical trials and clinical trials before mass production begins. But MIGAL thinks development could be fast-tracked to receive safety approval in 90 days. Akunis reportedly has ordered his ministry’s director-general to accelerate the process.”
https://www.sfgate.com/science/article/COVID-19-coronavirus-vaccine-Israel-15093659.php
